Travere Therapeutics Quote - TVTX

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

20.5103

Bid

20.49

Ask

20.54

Volume

545,075

20.47 Day's Range 21.17

5.12 52 Week Range 25.29

Market Cap

1.601B

Previous Close

20.64

Open

20.71

Last Trade

20.5

Last Trade Time

12:34:07

Financial Volume

US$ 11,365,986

VWAP

20.8522

Average Volume (3m)

1,526,104

Shares Outstanding

78,049,928

Dividend Yield

PE Ratio

-14.40

Earnings Per Share (EPS)

-1.43

Revenue

145.24M

Net Profit

-111.4M

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

travere.com

Headquarters

Lewes, Delaware, USA

Founded

Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TVTX. The last closing price for Travere Therapeutics was US$20.64. Over the last year, Travere Therapeutics shares have traded in a share price range of US$ 5.12 to US$ 25.29.

Travere Therapeutics currently has 78,049,928 shares outstanding. The market capitalization of Travere Therapeutics is US$1.61 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -14.40.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.9897	-4.60325581395	21.5	22.9	20.39	2004600	21.21446373	CS
4	-0.6797	-3.20764511562	21.19	25.29	19.67	2020412	22.20197097	CS
12	1.0603	5.45141388175	19.45	25.29	16.588	1526104	20.16511723	CS
26	11.4303	125.884361233	9.08	25.29	8.83	1712236	17.38447652	CS
52	12.3103	150.125609756	8.2	25.29	5.12	1422492	13.49029578	CS
156	-6.6297	-24.4277818718	27.14	30.35	5.12	1260657	15.45630567	CS
260	-4.6397	-18.448111332	25.15	33.0899	5.12	1103224	16.84169189	CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?

The current share price of Travere Therapeutics is US$ 20.5103

How many Travere Therapeutics shares are in issue?

Travere Therapeutics has 78,049,928 shares in issue

What is the market cap of Travere Therapeutics?

The market capitalisation of Travere Therapeutics is USD 1.61B

What is the 1 year trading range for Travere Therapeutics share price?

Travere Therapeutics has traded in the range of US$ 5.12 to US$ 25.29 during the past year

What is the PE ratio of Travere Therapeutics?

The price to earnings ratio of Travere Therapeutics is -14.4

What is the cash to sales ratio of Travere Therapeutics?

The cash to sales ratio of Travere Therapeutics is 11.04

What is the reporting currency for Travere Therapeutics?

Travere Therapeutics reports financial results in USD

What is the latest annual turnover for Travere Therapeutics?

The latest annual turnover of Travere Therapeutics is USD 145.24M

What is the latest annual profit for Travere Therapeutics?

The latest annual profit of Travere Therapeutics is USD -111.4M

What is the registered address of Travere Therapeutics?

The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958

What is the Travere Therapeutics website address?

The website address for Travere Therapeutics is travere.com

Which industry sector does Travere Therapeutics operate in?

Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
STAKSTAK Inc	US$ 3.81 (145.81%)	112.83k
ACONAclarion Inc	US$ 4.6996 (78.69%)	2.96M
TRNRInteractive Strength Inc	US$ 2.565 (67.65%)	155.47M
ORGOOrganogenesis Holdings Inc	US$ 5.0792 (65.45%)	45.99M
PMAXPowell Max Ltd	US$ 0.5106 (43.43%)	125.63M
NVNINVNI Group Ltd	US$ 0.9171 (-54.15%)	64.49M
PRAXPraxis Precision Medicines Inc	US$ 39.14 (-39.81%)	2.05M
SPGCSacks Parente Golf Inc	US$ 0.2452 (-39.61%)	33.76M
SAGSAG Holdings Ltd	US$ 1.21 (-37.95%)	492.34k
DHDefinitive Healthcare Corporation	US$ 3.065 (-37.70%)	5.54M
NVDANVIDIA Corporation	US$ 119.42 (-0.61%)	234.24M
TRNRInteractive Strength Inc	US$ 2.565 (67.65%)	155.47M
PMAXPowell Max Ltd	US$ 0.5106 (43.43%)	125.63M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 12.53 (0.48%)	115.79M
ADTXAditxt Inc	US$ 0.0635 (-8.37%)	112.09M